相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
Young Jun Seo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Divergent Kinetics Differentiate the Mechanism of Action of Two HDAC Inhibitors
Astrid M. Kral et al.
BIOCHEMISTRY (2014)
Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories
Johannes Graeff et al.
CELL (2014)
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor
Joey L. Methot et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
The Potential of HDAC Inhibitors as Cognitive Enhancers
Johannes Graeff et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
Class I HDAC imaging using [3H] CI-994 autoradiography
Yajie Wang et al.
EPIGENETICS (2013)
Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia
Michel Weiwer et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Benjamin E. L. Lauffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif
Florence F. Wagner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Loss of Histone Deacetylase 2 Improves Working Memory and Accelerates Extinction Learning
Michael J. Morris et al.
JOURNAL OF NEUROSCIENCE (2013)
Crebinostat: A novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity
Daniel M. Fass et al.
NEUROPHARMACOLOGY (2013)
Epigenetics and Psychiatry
Melissa Mahgoub et al.
NEUROTHERAPEUTICS (2013)
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Florence F. Wagner et al.
NEUROTHERAPEUTICS (2013)
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
Melissa Malvaez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Johannes Graeff et al.
NATURE (2012)
Expanding the Azaspiro[3.3]heptane Family: Synthesis of Novel Highly Functionalized Building Blocks
Johannes A. Burkhard et al.
ORGANIC LETTERS (2012)
Synaptic Deficits Are Rescued in the p25/Cdk5 Model of Neurodegeneration by the Reduction of β-Secretase (BACE1)
Paola Giusti-Rodriguez et al.
JOURNAL OF NEUROSCIENCE (2011)
HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
Guoyi Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Jerome C. Bressi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
Roel H. Wilting et al.
EMBO JOURNAL (2010)
Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
Myriam Rai et al.
PLOS ONE (2010)
Epigenetic Regulation in Substance Use Disorders
Susan C. McQuown et al.
CURRENT PSYCHIATRY REPORTS (2010)
HDAC2 negatively regulates memory formation and synaptic plasticity
Ji-Song Guan et al.
NATURE (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors
Marina Naldi et al.
PROTEOMICS (2009)
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
Joey L. Methot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
Ted Abe et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases
C. James Chou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Dohoon Kim et al.
NEURON (2008)
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity
Oscar M. Moradei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Distribution of histone deacetylases 1-11 in the rat brain
Ron S. Broide et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory
A Fischer et al.
NEURON (2005)
Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration
JM Alarcón et al.
NEURON (2004)
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
JC Cruz et al.
NEURON (2003)
分享论文
